Literature DB >> 11412039

Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells.

H Ikawa1, H Kameda, H Kamitani, S J Baek, J B Nixon, L C Hsi, T E Eling.   

Abstract

Cyclooxygenase-2 (COX-2) expression is up-regulated in colorectal cancer tissue. Peroxisome proliferator-activated receptors (PPARs) are expressed in human colorectal tissue and activation of PPARs can alter COX-2 expression. In macrophages, activation of PPARs down-regulates COX-2 expression. We examined the effect of PPARalpha and PPARgamma ligands on untreated and TNF-alpha-induced COX-2 expression in the human colorectal epithelial cell line HT-29. The expression of PPARalpha and PPARgamma was confirmed in these cells. TNF-alpha, an inflammatory cytokine, increased COX-2 expression via the NFkappaB pathway. In the absence of TNF-alpha, WY14643 (PPARalpha activator) caused an increase, while BRL49653 (PPARgamma activator) did not alter COX-2 expression. When HT-29 cells were incubated with TNF-alpha and WY14643, a further increase in COX-2 expression was detected. Incubation with TNF-alpha and BRL49653 caused an additional twofold increase in COX-2 expression. Our results suggest that both PPARalpha signaling and TNF-alpha signaling increase COX-2 expression by independent pathways, while PPARgamma stimulates COX-2 expression by up-regulation of the TNF-alpha pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11412039     DOI: 10.1006/excr.2001.5233

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.

Authors:  Yuhong Luo; Cen Xie; Chad N Brocker; Jie Fan; Xuan Wu; Lijin Feng; Qiong Wang; Jie Zhao; Dasheng Lu; Mayank Tandon; Maggie Cam; Kristopher W Krausz; Weiwei Liu; Frank J Gonzalez
Journal:  Gastroenterology       Date:  2019-05-30       Impact factor: 22.682

2.  Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.

Authors:  Govindaiah Vinukonda; Anna Csiszar; Furong Hu; Krishna Dummula; Nishi Kant Pandey; Muhammad T Zia; Nicholas R Ferreri; Zoltan Ungvari; Edmund F LaGamma; Praveen Ballabh
Journal:  Brain       Date:  2010-05-20       Impact factor: 13.501

3.  Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma.

Authors:  Sylvia Stadlmann; Uwe Gueth; Edward Wight; Leoni A Kunz-Schughart; Arndt Hartmann; Gad Singer
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

4.  An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes.

Authors:  C David Bell; Sergio Vidal; Kalman Kovacs; Eva Horvath; Fabio Rotondo
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 5.  RNAi-based strategies for cyclooxygenase-2 inhibition in cancer.

Authors:  Antonio Strillacci; Cristiana Griffoni; Maria Chiara Valerii; Giorgia Lazzarini; Vittorio Tomasi; Enzo Spisni
Journal:  J Biomed Biotechnol       Date:  2010-06-13

6.  Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.

Authors:  Daniela Bonofiglio; Erika Cione; Hongyan Qi; Attilio Pingitore; Mariarita Perri; Stefania Catalano; Donatella Vizza; Maria Luisa Panno; Giuseppe Genchi; Suzanne A W Fuqua; Sebastiano Andò
Journal:  Am J Pathol       Date:  2009-07-30       Impact factor: 4.307

Review 7.  Peroxisome Proliferator-Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract.

Authors:  Yue-Xin Guo; Bo-Ya Wang; Han Gao; Rong-Xuan Hua; Lei Gao; Cheng-Wei He; Ying Wang; Jing-Dong Xu
Journal:  Front Mol Biosci       Date:  2022-04-26

8.  The Role of PPARs in the Endothelium: Implications for Cancer Therapy.

Authors:  David Bishop-Bailey; Karen E Swales
Journal:  PPAR Res       Date:  2008-11-24       Impact factor: 4.964

9.  Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor.

Authors:  Shlomo Bakshi; Xiang Zhang; Sonia Godoy-Tundidor; Robert Yuk Sing Cheng; Maureen A Sartor; Mario Medvedovic; Shuk-Mei Ho
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

10.  Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours.

Authors:  A Sakamoto; Y Yokoyama; M Umemoto; M Futagami; T Sakamoto; X Bing; H Mizunuma
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.